S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market

National Vision (EYE) Stock Forecast & Price Target

$19.52
-0.12 (-0.61%)
(As of 04/12/2024 08:51 PM ET)

National Vision Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Hold
Based on 5 Analyst Ratings

Analysts' Consensus Price Target

$23.86
22.22% Upside
High Forecast$34.00
Average Forecast$23.86
Low Forecast$19.00
TypeCurrent Forecast
4/16/23 to 4/15/24
1 Month Ago
3/17/23 to 3/16/24
3 Months Ago
1/16/23 to 1/16/24
1 Year Ago
4/16/22 to 4/16/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
6 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$23.86$23.86$24.50$31.00
Predicted Upside22.22% Upside9.01% Upside15.02% Upside24.20% Upside
Get National Vision Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

EYE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EYE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

National Vision Stock vs. The Competition

TypeNational VisionMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.68
2.49
Consensus RatingHoldModerate BuyHold
Predicted Upside22.22% Upside768.32% Upside10.21% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/28/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$18.00 ➝ $20.00-12.89%
11/13/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$20.00 ➝ $19.00+6.56%
8/11/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$20.00 ➝ $23.00+16.22%
7/27/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$28.00 ➝ $22.00-11.15%
7/27/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$30.00 ➝ $21.00-15.19%
5/12/2023Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$23.00 ➝ $28.00+17.85%
5/4/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$45.00 ➝ $34.00+55.11%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:41 AM ET.

EYE Price Target - Frequently Asked Questions

What is National Vision's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for National Vision stock is Hold based on the current 5 hold ratings for EYE. The average twelve-month price prediction for National Vision is $23.86 with a high price target of $34.00 and a low price target of $19.00. Learn more on EYE's analyst rating history.

Do Wall Street analysts like National Vision more than its competitors?

Analysts like National Vision less than other Medical companies. The consensus rating for National Vision is Hold while the average consensus rating for medical companies is Moderate Buy. Learn more on how EYE compares to other companies.

Does National Vision's stock price have much upside?

According to analysts, National Vision's stock has a predicted upside of 7.67% based on their 12-month stock forecasts.

What analysts cover National Vision?

National Vision has been rated by The Goldman Sachs Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:EYE) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners